An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Who Have Completed MEX-DM-302 Study.
Clinical trial NCT06549400 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06549400
- Sponsor
- Lupin Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-12
- Primary completion
- 2028-05-29
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.